199 related articles for article (PubMed ID: 31482319)
1. Recovery from Copperhead Snake Envenomation: Role of Age, Sex, Bite Location, Severity, and Treatment.
Lavonas EJ; Burnham RI; Schwarz J; Quackenbush E; Lewis B; Rose SR; Greene S; Toschlog EA; Charlton NP; Mullins ME; Schwartz R; Denning D; Sharma K; Kleinschmidt K; Bush SP; Anderson VE; Ginde AA; Gerardo CJ
J Med Toxicol; 2020 Jan; 16(1):17-23. PubMed ID: 31482319
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery From Copperhead Snake Envenomation: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
Gerardo CJ; Quackenbush E; Lewis B; Rose SR; Greene S; Toschlog EA; Charlton NP; Mullins ME; Schwartz R; Denning D; Sharma K; Kleinschmidt K; Bush SP; Ryan S; Gasior M; Anderson VE; Lavonas EJ
Ann Emerg Med; 2017 Aug; 70(2):233-244.e3. PubMed ID: 28601268
[TBL] [Abstract][Full Text] [Related]
3. Early administration of Fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients.
Anderson VE; Gerardo CJ; Rapp-Olsson M; Bush SP; Mullins ME; Greene S; Toschlog EA; Quackenbush E; Rose SR; Schwartz RB; Charlton NP; Lewis B; Kleinschmidt KC; Sharma K; Lavonas EJ
Clin Toxicol (Phila); 2019 Jan; 57(1):25-30. PubMed ID: 30175628
[TBL] [Abstract][Full Text] [Related]
4. Adverse Events in the Efficacy of Crotalidae Polyvalent Immune Fab Antivenom vs Placebo in Recovery from Copperhead Snakebite Trial.
Mullins ME; Gerardo CJ; Bush SP; Rose SR; Greene S; Quackenbush EB; Lewis B; Anderson VE; Kleinschmidt KC; Schwarz RB; Charlton NP; Toschlog EA; Sharma K; Denning DA; Lavonas EJ
South Med J; 2018 Dec; 111(12):716-720. PubMed ID: 30512122
[TBL] [Abstract][Full Text] [Related]
5. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite.
Lavonas EJ; Gerardo CJ; O'Malley G; Arnold TC; Bush SP; Banner W; Steffens M; Kerns WP
Ann Emerg Med; 2004 Feb; 43(2):200-6. PubMed ID: 14747809
[TBL] [Abstract][Full Text] [Related]
6. Predictors of FabAV use in copperhead envenomation.
Ramirez-Cueva F; Larsen A; Knowlton E; Baab K; Rainey Kiehl R; Hendrix A; Condren M; Woslager M
Clin Toxicol (Phila); 2022 May; 60(5):609-614. PubMed ID: 34989644
[TBL] [Abstract][Full Text] [Related]
7. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')
Gerardo CJ; Vissoci JR; Brown MW; Bush SP
Clin Toxicol (Phila); 2017 Feb; 55(2):109-114. PubMed ID: 27806644
[TBL] [Abstract][Full Text] [Related]
8. Control of venom-induced tissue injury in copperhead snakebite patients: a post hoc sub-group analysis of a clinical trial comparing F(ab')
Gerardo CJ; Keyler DE; Rapp-Olson M; Dart RC
Clin Toxicol (Phila); 2022 Apr; 60(4):521-523. PubMed ID: 34590543
[TBL] [Abstract][Full Text] [Related]
9. Clinically Significant Envenomation From Postmortem Copperhead (Agkistrodon contortrix).
Emswiler MP; Griffith FP; Cumpston KL
Wilderness Environ Med; 2017 Mar; 28(1):43-45. PubMed ID: 27876196
[TBL] [Abstract][Full Text] [Related]
10. Use of Crotalidae equine immune F(ab')
Wilson BZ; Larsen J; Smelski G; Dudley S; Shirazi FM
Clin Toxicol (Phila); 2021 Nov; 59(11):1023-1026. PubMed ID: 33703984
[TBL] [Abstract][Full Text] [Related]
11. Antivenom Treatment Is Associated with Fewer Patients using Opioids after Copperhead Envenomation.
Freiermuth CE; Lavonas EJ; Anderson VE; Kleinschmidt KC; Sharma K; Rapp-Olsson M; Gerardo C;
West J Emerg Med; 2019 May; 20(3):497-505. PubMed ID: 31123552
[TBL] [Abstract][Full Text] [Related]
12. Comments on "Comparing cost of F(ab')
Mullins ME; Nguyen KR; Filip AB; Liss DB; Baumgartner KT
Am J Emerg Med; 2024 Feb; 76():238-239. PubMed ID: 38143157
[No Abstract] [Full Text] [Related]
13. Prospective study of recovery from copperhead snake envenomation: an observational study.
Lavonas EJ; Gerardo CJ;
BMC Emerg Med; 2015 May; 15():9. PubMed ID: 25975429
[TBL] [Abstract][Full Text] [Related]
14. Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review.
Lavonas EJ; Schaeffer TH; Kokko J; Mlynarchek SL; Bogdan GM
BMC Emerg Med; 2009 Jun; 9():13. PubMed ID: 19545426
[TBL] [Abstract][Full Text] [Related]
15. Marked Hypofibrinogenemia and Gastrointestinal Bleeding After Copperhead (Agkistrodon contortrix) Envenomation.
Kopec KT; Yen M; Bitner M; Evans CS; Gerardo CJ
Wilderness Environ Med; 2015 Dec; 26(4):488-90. PubMed ID: 26432425
[TBL] [Abstract][Full Text] [Related]
16. Presumed Copperhead Snakebite and Antivenom Administration in the Third Trimester.
Yano J; Zerden M; German B
Wilderness Environ Med; 2019 Dec; 30(4):446-449. PubMed ID: 31699647
[TBL] [Abstract][Full Text] [Related]
17. Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation.
Gerardo CJ; Lavonas EJ; McKinney RE
Clin Trials; 2014 Oct; 11(5):560-4. PubMed ID: 25055811
[TBL] [Abstract][Full Text] [Related]
18. Acute hypersensitivity reaction to Crotalidae polyvalent immune Fab (CroFab) as initial presentation of galactose-α-1,3-galactose (α-gal) allergy.
Rizer J; Brill K; Charlton N; King J
Clin Toxicol (Phila); 2017 Aug; 55(7):668-669. PubMed ID: 28443380
[TBL] [Abstract][Full Text] [Related]
19. Comment on "Early administration of fab antivenom resulted in faster limb recovery in copperhead snake envenomation patients".
Shah KR; Beuhler MC
Clin Toxicol (Phila); 2020 Mar; 58(3):222-223. PubMed ID: 31140332
[No Abstract] [Full Text] [Related]
20. In Response to "The Efficacy of Crotalidae Polyvalent Immune Fab (Ovine) Antivenom Versus Placebo Plus Optional Rescue Therapy on Recovery from Copperhead Snake Envenomation".
Chiang W; Harding SA; Tassin SA; Nguyen V; Su M
Ann Emerg Med; 2017 Dec; 70(6):930-931. PubMed ID: 29157700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
